Risk-stratification models for primary prevention of sudden cardiac death in hypertrophic cardiomyopathy
North American model | European model |
---|---|
An implantable cardioverter-defibrillator (ICD) is reasonable (class IIa recommendation, level of evidence C—limited evidence) if any of the following are present:
Or if the patient has any other risk factor or modifier for sudden cardiac death and either of the following:
| The following factors are used to electronically calculate the 5-year risk of sudden cardiac death:
5-year risk < 4%: an ICD is generally not indicated 5-year risk ≥ 4% to < 6%: an ICD may be considered 5-year risk ≥ 6%: an ICD should be considered |
Based on information in references 9 and 30.